Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Rhea-AI Summary

Obagi Medical (NASDAQ: WALD) announced a collaboration with It’s a Secret Med Spa on Feb 25, 2026 to enroll premium med spa locations in the ALOHA real-world program evaluating saypha® MagIQ™. The program will capture standardized real-world data across participating sites and integrate Obagi protocols.

It’s a Secret brings 15 high-end locations and luxury clinical experience to support evaluation and patient outcomes.

Key Figures

Obagi experience: 35+ years Journal year: 2025 Journal volume/issue: 11(7):487 +2 more

5 metrics

Obagi experience 35+ years Legacy of Obagi Medical in advanced skincare

Journal year 2025 Publication year for Gels article on HA crosslinking technologies

Journal volume/issue 11(7):487 Citation details for hyaluronic acid filler comparison paper

Top professional brands Top 10 Obagi among Top 10 Professional Skin Care Brands in the U.S. in 2024

Med spa locations 15 locations It’s a Secret Med Spa high-end sites with growing national presence

Market Reality Check

Price: $1.76 Vol: Volume 50,560 is at 0.78x...

normal vol

$1.76 Last Close

Volume Volume 50,560 is at 0.78x the 20-day average of 65,086, indicating typical interest before this update. normal

Technical Shares at $1.76 are trading below the 200-day MA of $2.04 and about 50% under the 52-week high of $3.54.

Peers on Argus

WALD gained 2.33% while peers were mixed: EWCZ +0.18%, DSY +4.57%, ACU -0.17%, G...

WALD gained 2.33% while peers were mixed: EWCZ +0.18%, DSY +4.57%, ACU -0.17%, GROV -6.16%, SKIN -2.93%. The scattered moves point to stock-specific drivers rather than a coordinated sector move.

Historical Context

5 past events · Latest: Feb 17 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 17	ALOHA collaboration	Positive	+1.1%	Partnered with Aesthetic Record to run ALOHA real-world data program.
Feb 06	ALOHA collaboration	Positive	+3.5%	DermFx partnership to deploy ALOHA with standardized data capture.
Feb 05	ALOHA collaboration	Positive	-4.9%	Moxie collaboration for ALOHA real-world initiative across practices.
Feb 03	Product launch	Positive	+5.3%	Introduced new two-step Lip Therapy protocol and pricing details.
Jan 30	ALOHA collaboration	Positive	+13.5%	VIO Med Spa launch partner to generate real-world MagIQ evidence.

Pattern Detected

Recent product and ALOHA collaboration news has usually seen positive price reactions, with one notable divergence on similar partnership news.

Recent Company History

Over the past month, Waldencast has consistently expanded Obagi’s footprint through ALOHA collaborations and product launches. Partnerships with VIO Med Spa, Moxie, DermFx, and Aesthetic Record all focused on generating structured real-world data for Obagi® saypha® MagIQ™ across multi-site networks, while a new Lip Therapy protocol launch on Feb 3, 2026 also drew interest. Today’s It’s a Secret Med Spa collaboration continues this strategy of evidence-based rollout, adding another premium network to the same real-world evaluation framework.

Market Pulse Summary

This announcement adds another premium med spa network to Obagi’s ALOHA real-world evidence strategy...

Analysis

This announcement adds another premium med spa network to Obagi’s ALOHA real-world evidence strategy for saypha® MagIQ™, extending prior collaborations with groups like VIO, DermFx, and Aesthetic Record. The focus on standardized data capture, multi-site implementation, and integration with Obagi protocols continues a clear execution theme. Investors may watch how these partnerships scale, what real-world outcomes emerge, and how they complement existing Obagi product launches.

Key Terms

real-world evidence, hyaluronic acid, injectable, hyperpigmentation, +1 more

5 terms

real-world evidence medical

"announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi"

Real-world evidence is information gathered from everyday sources like patient records, insurance claims, or everyday experiences, rather than controlled experiments or clinical trials. It helps investors understand how products or policies perform in real life, providing a more complete picture of their effectiveness and value beyond official tests. This type of evidence can influence decision-making by offering insights based on actual, everyday outcomes.

hyaluronic acid medical

"Hyaluronic Acid (ALOHA) Program. It’s a Secret Med Spa will help generate real-world data"

A naturally occurring molecule that acts like a tiny sponge, holding water in skin, joints and eyes to keep tissues plump and lubricated. Investors track products containing hyaluronic acid because they power large markets—such as skincare, injectable fillers, eye drops and wound treatments—so demand, regulatory approvals, manufacturing capacity and raw-material costs can meaningfully affect a company’s sales and profit outlook.

injectable medical

"launching this innovative injectable, and we have the clinical expertise"

A product described as an "injectable" is a medicine or vaccine formulated to be given by needle, syringe, or infusion rather than taken by mouth. For investors it matters because injectables often require specialized manufacturing, cold storage and trained staff to administer, which can raise costs, create supply-chain risks and form higher barriers to competitors—factors that influence a product’s price, market reach and long-term revenue potential.

hyperpigmentation medical

"Initially known for its leadership in the treatment of hyperpigmentation with the Obagi"

Hyperpigmentation is the darkening of patches of skin caused by extra pigment accumulating in certain areas, much like a coffee stain forming on fabric. It matters to investors because it is a common, visible condition that creates steady demand for prescription drugs, over‑the‑counter creams, cosmetic procedures and related diagnostics; trends in prevalence, new treatments or regulatory changes can directly affect revenue and market risk for companies in dermatology and beauty.

FDA pivotal trials regulatory

"translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday"

Pivotal FDA trials are the main clinical studies designed to show whether a new drug or medical device works and is safe enough for regulatory approval; they are often the decisive evidence the agency relies on. Think of them as the final exam for a treatment — strong results can unlock market access and future sales, while failures can stop development and affect investor value.

AI-generated analysis. Not financial advice.

It’s a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and outstanding patient results across its growing network of high-end locations

NEW YORK and DALLAS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced It’s a Secret Med Spa as a key partner in the Aesthetics Leadership with Obagi’s Hyaluronic Acid (ALOHA) Program. It’s a Secret Med Spa will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple locations and structured evaluation programs.

“This partnership with Obagi makes perfect sense for us. They’re taking a thoughtful, evidence-based approach to launching this innovative injectable, and we have the clinical expertise, luxury patient experience, and high-performance environment to evaluate how trial data performs in real-world premium med spa settings,” said Garret Gay, Vice President of Sales at It’s a Secret Med Spa. “Our providers deliver advanced aesthetic treatments every day to discerning clients who expect the absolute best in results, service, and atmosphere. That elevated experience matters. The ALOHA Program is an ideal fit for premium, high-touch med spas like ours — giving us access to best-in-class protocols, real-world insights, and the ability to integrate saypha^® MagIQ™ with the complete Obagi ecosystem to deliver exceptional outcomes for our clients.”

The ALOHA Real-World Program is designed to give It’s a Secret Med Spa providers hands-on experience with Obagi saypha^® MagIQ™ while evaluating complete Obagi protocols. This approach aims to drive patient satisfaction and strengthen relationships between clients and their providers. The program includes a real-world clinical initiative supplemented by a structured evaluation process across participating It’s a Secret Med Spa locations, with standardized data capture.

“Partnering with It’s a Secret Med Spa is a clear statement of our intent to launch this new injectable on a foundation of robust clinical evidence, education, and integrated patient outcomes,” said Drew Fine, U.S. General Manager, Professional Channel. “The ALOHA collaboration with It’s a Secret brings together luxury clinical expertise, exceptional patient experience, and a shared passion for delivering extraordinary results — reinforcing Obagi’s commitment to supporting high-performing practices of all models and helping elevate the standard of care across the premium med spa landscape.”

Obagi^® saypha^® MagIQ™, developed by Croma-Pharma GmbH, utilizes proprietary MACRO Core Technology to create a stable three-dimensional hyaluronic acid matrix. The technology is designed to deliver natural-looking results with category-leading performance, including high usable HA content upon injection, consistent gel distribution, and a predictable injection force and swelling profile¹.

For more information about ALOHA, visit https://obagi-professional.com.

About Obagi Medical
Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm^® System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024,² Obagi Medical empowers individuals to achieve healthy, beautiful skin. More information about Obagi Medical is available on the brand's website, https://www.obagi.com.

About It’s a Secret Med Spa
It’s a Secret Med Spa is a premier luxury medical spa experience offering the most advanced aesthetic treatments in a sophisticated and highly personalized environment. Specializing in injectables, laser treatments, skin rejuvenation, and wellness services, It’s a Secret is the largest provider of neurotoxins, dermal fillers, and injectable medical aesthetics in Texas & the Southwestern United States. Known for exceptional results, white-glove service, and an uncompromising focus on client satisfaction. With 15 high-end locations and a growing national presence, It’s a Secret Med Spa delivers elite-level care to clients who demand the very best. For more information, visit https://secretmedspa.com.

About Waldencast plc
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. For more information please visit: https://ir.waldencast.com.

Media Contact:
obagi@behrmancesa.com

Source: Waldencast plc

¹ Puljic A, Frank K, Cohen J, Otto K, Mayr J, Hugh-Bloch A, Kuroki-Hasenöhrl, D. A Scientific Framework for Comparing Hyaluronic Acid Filler Crosslinking Technologies. Gels. 2025; 11(7):487
² Among the Top 10 Professional Skin Care Brands in the U.S., According to Kline’s 2024 Global Professional Skin Care Series (China, Europe and the U.S.)

FAQ

What is the ALOHA Program announced by Obagi Medical (WALD) on Feb 25, 2026?

The ALOHA Program is a real-world clinical initiative to evaluate injectable performance in practice settings. According to Obagi, it provides standardized data capture, hands-on training, and integration with Obagi protocols across participating med spa locations to assess patient outcomes.

How will It’s a Secret Med Spa participate in Obagi’s ALOHA Program (WALD)?

It’s a Secret will serve as a premier partner providing multiple high-end locations and clinical experience. According to It’s a Secret, providers will follow structured evaluation programs and standardized data capture to translate pivotal trial results into everyday premium med spa practice.

What product is being evaluated in the Obagi ALOHA Program (WALD)?

The program evaluates Obagi saypha® MagIQ™, a hyaluronic acid injectable developed by Croma-Pharma. According to Obagi, the product uses MACRO Core Technology intended to deliver consistent gel distribution, high usable HA content, and predictable injection and swelling profiles.

Does the ALOHA collaboration with It’s a Secret Med Spa include standardized data collection?

Yes. The collaboration includes a structured evaluation process with standardized data capture across participating locations. According to Obagi, this is designed to generate real-world evidence to compare clinical trial safety and efficacy with everyday practice outcomes.

How extensive is It’s a Secret Med Spa’s presence for the ALOHA Program (WALD)?

It’s a Secret Med Spa brings 15 high-end locations and a growing national presence to the program. According to It’s a Secret, the network is the largest provider of injectables in Texas and the Southwestern U.S., offering luxury, high-touch patient experiences.